Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-07-12

FDA Approved: LACOSAMIDE — Supplemental Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Camber Pharmaceuticals' supplemental application for lacosamide, a generic antiseizure medication used as adjunctive therapy for partial-onset seiz…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lacosamide (Lacosamide)

Snippet

SUPPL AP for LACOSAMIDE (LACOSAMIDE)